Rallybio insider group buys 16,209 RLYB shares
Rallybio Corp disclosed that private investment funds and separately managed accounts managed by ADAR1 Capital Management, LLC made open-market purchases of Rallybio common stock.
Rhea-AI Filing Summary
Rallybio Corp disclosed that private investment funds and separately managed accounts managed by ADAR1 Capital Management, LLC made open-market purchases of Rallybio common stock. Across May 18–19, 2026, these ADAR1-managed vehicles bought a total of 16,209 shares at weighted average prices near $14 per share.
Following these transactions, the ADAR1-managed funds and accounts indirectly held 926,352 Rallybio shares. ADAR1 Capital Management and Daniel Schneeberger, each a 10% owner, may be deemed indirect beneficial owners but expressly disclaim beneficial ownership beyond any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 10,000 | $13.9822 | $140K |
| Purchase | Common Stock | 200 | $13.80 | $3K |
| Purchase | Common Stock | 6,009 | $13.9759 | $84K |
Footnotes (4)
- F1. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.9100 to $14.0000, inclusive. Each Reporting Person undertakes to provide Rallybio Corp, any security holder of Rallybio Corp or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.9350 to $14.0000, inclusive. Each Reporting Person undertakes to provide to Rallybio Corp, any security holder of Rallybio Corp or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC and separately managed accounts of ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
- F4. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
indirectly beneficially owned financial
separately managed accounts financial
pecuniary interest financial
Section 16 of the Securities Exchange Act of 1934 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Rallybio Corp (RLYB) report in this Form 4?
What is the resulting Rallybio (RLYB) position after the Form 4 transactions?
Are the Rallybio (RLYB) insider trades attributed personally to Daniel Schneeberger?
What do the weighted average prices in the Rallybio (RLYB) Form 4 mean?
AI-generated analysis. How Rhea-AI works. Not financial advice.